These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 72076)

  • 21. Antibody response in thirteen patients with Bacteroides fragilis infections.
    Schwan A; Rydén AC
    Scand J Infect Dis; 1978; 10(3):213-8. PubMed ID: 362516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demonstration of heat-labile antigen(s) of Bacteroides fragilis associated with non-homogeneous immunofluorescent staining.
    Schwan A; Danielsson D; Forsum U
    Acta Pathol Microbiol Immunol Scand B; 1982 Feb; 90(1):13-9. PubMed ID: 6177189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates.
    Pantosti A; Colangeli R; Tzianabos AO; Kasper DL
    J Clin Microbiol; 1995 Oct; 33(10):2647-52. PubMed ID: 8567899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteroides fragilis strains express multiple capsular polysaccharides.
    Pantosti A; Tzianabos AO; Reinap BG; Onderdonk AB; Kasper DL
    J Clin Microbiol; 1993 Jul; 31(7):1850-5. PubMed ID: 8349763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative determination of the serum antibody response to the capsular polysaccharide of Bacteroides fragilis subspecies fragilis in women with pelvic inflammatory disease.
    Kasper DL; Eschenbach DA; Hayes ME; Holmes KK
    J Infect Dis; 1978 Jul; 138(1):74-80. PubMed ID: 98597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteroides fragilis subspecies in clinical isolates.
    Polk BF; Kasper DL
    Ann Intern Med; 1977 May; 86(5):569-71. PubMed ID: 322563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a polyvalent conjugate of Bacterroides fragilis by fluorescent antibody staining.
    Lambe DW
    Am J Clin Pathol; 1979 Jan; 71(1):97-101. PubMed ID: 369356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody response following subcutaneous and intraperitoneal injection of Bacteroides fragilis in rabbits.
    Landay ME
    Eur J Clin Microbiol; 1982 Aug; 1(4):248-51. PubMed ID: 7173187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crossed immunoelectrophoresis and enzyme-linked immunosorbent assay of the cell-surface antigens of Bacteroides fragilis.
    Cousland G; Poxton IR
    J Gen Microbiol; 1984 Mar; 130(3):645-55. PubMed ID: 6726180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibody titer to Bacteroides fragilis is increased in Crohn disease patients with fistula development].
    Pietsch M; Brake BA; Schulz TF; Dierich MP
    Z Gastroenterol; 1986 May; 24(5):269-75. PubMed ID: 2425502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of the antigenic structure of the Bacteroides fragilis species.
    Romond C; Beerens H
    Infection; 1980; 8 Suppl 2():S142. PubMed ID: 7005093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staphylococcus aureus protein A--antibody-mediated haemagglutination for the analysis of cross-reactivity between phenol-water extracts of Bacteroides fragilis.
    Srinivasakumar N; Rao RS
    J Med Microbiol; 1986 Jun; 21(4):343-7. PubMed ID: 3723586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic properties of LPS extracted from Bacteroides fragilis enterotoxin producing strains.
    Meisel-Mikołajczyk F; Kot K; Kłos W; Rouyan GS; Mieszała M; Gamian A
    Acta Microbiol Pol; 1999; 48(2):153-61. PubMed ID: 10581671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The distribution of Bacteroides fragilis serotypes amongst clinical strains.
    Elhag KM; Tabaqchali S
    J Hyg (Lond); 1978 Aug; 81(1):89-97. PubMed ID: 690426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Bacteroides infection by counter immunoelectrophoresis test.
    Lalitha MK; Mathai E; Elias L; Anandi V; Kalpana CR
    Indian J Med Res; 1991 May; 93():171-3. PubMed ID: 1937595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of the antigenic composition of the fragilis group of Bacteroides.
    Elhag KM; Alkarmi TO
    J Med Microbiol; 1991 Aug; 35(2):118-22. PubMed ID: 1875392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a direct fluorescent antibody staining method for rapid identification of members of the bacteroides fragilis group.
    DeGirolami PC; Mepani CP
    Am J Clin Pathol; 1981 Jul; 76(1):78-82. PubMed ID: 7020409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid identification of clinically important bacteroides by coagglutination method.
    Lalitha MK; Anandi V; Elias L; Kalpana CR
    Indian J Med Res; 1991 Mar; 93():98-102. PubMed ID: 1855827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The humoral antibody response to Bacteroides fragilis infections in humans.
    Lindberg AA; Weintraub A; Nord CE
    Scand J Infect Dis Suppl; 1979; (19):46-51. PubMed ID: 288165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity of immunoglobulin M antibodies in normal human serum that participate in opsonophagocytosis and intracellular killing of Bacteroides fragilis and Bacteroides thetaiotaomicron by by human polymorphonuclear leukocytes.
    Bjornson AB; Bjornson HS; Kitko BP
    Infect Immun; 1980 Oct; 30(1):263-71. PubMed ID: 6160104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.